Literature DB >> 31177358

Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies.

Woei-Kang Liew1, Koh-Cheng Thoon2, Chia-Yin Chong2, Natalie W H Tan2, Duo-Tong Cheng2, Bianca S W Chan1, Michelle S Y Ng3, Lena Das1, Thaschawee Arkachaisri1, Chiung-Hui Huang4, Jyn-Ling Kuan5, Louis Y A Chai6,7, Mark Jean Aan Koh8.   

Abstract

Immunodeficiency secondary to anti-interferon-gamma (anti-IFN-γ) autoantibodies was first described in 2004 as an acquired defect in the IFN-γ pathway leading to susceptibility to multiple opportunistic infections, including dimorphic fungi, parasites, and bacteria, especially tuberculosis and non-tuberculous mycobacterium (NTM) species. It has so far only been described in adult patients. We present 2 cases of disseminated NTM infections in otherwise immunocompetent children. A 16-year-old girl with Sweet's syndrome-like neutrophilic dermatosis developed recurrent fever and cervical lymphadenitis secondary to Mycobacterium abscessus. A 10-year-old boy with a history of prolonged fever, aseptic meningitis, aortitis, and arteritis in multiple blood vessels developed thoracic vertebral osteomyelitis secondary to Mycobacterium avium complex. Both patients were found to have positive serum neutralizing anti-IFNγ autoantibodies. Testing for anti-IFNγ autoantibodies should be considered in otherwise healthy immunocompetent hosts with recurrent or disseminated NTM infection. This represents a phenocopy of primary immunodeficiency which has been recently described only in adults. We report the first two cases of this phenomenon to affect children.

Entities:  

Keywords:  Anti-interferon-gamma autoantibodies; immunodeficiency; non-tuberculous mycobacteria

Mesh:

Substances:

Year:  2019        PMID: 31177358     DOI: 10.1007/s10875-019-00652-1

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.542


  19 in total

1.  Anti-IFN-γ autoantibodies are strongly associated with HLA-DR*15:02/16:02 and HLA-DQ*05:01/05:02 across Southeast Asia.

Authors:  Cheng-Lung Ku; Chia-Hao Lin; Su-Wei Chang; Chen-Chung Chu; Jasper F W Chan; Xiao-Fei Kong; Chen-Hsiang Lee; Emily A Rosen; Jing-Ya Ding; Wen-I Lee; Jacinta Bustamante; Torsten Witte; Han-Po Shih; Chen-Yen Kuo; Ploenchan Chetchotisakd; Sasisopin Kiertiburanakul; Yupin Suputtamongkol; Kwok-Yung Yuen; Jean-Laurent Casanova; Steven M Holland; Rainer Doffinger; Sarah K Browne; Chih-Yu Chi
Journal:  J Allergy Clin Immunol       Date:  2015-10-29       Impact factor: 10.793

Review 2.  Natural and therapeutically-induced antibodies to cytokines.

Authors:  R P Revoltella
Journal:  Biotherapy       Date:  1998

3.  Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections.

Authors:  Smita Y Patel; Li Ding; Margaret R Brown; Larry Lantz; Ted Gay; Stuart Cohen; Lenna A Martyak; Bernard Kubak; Steven M Holland
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

4.  Adult-onset immunodeficiency in Thailand and Taiwan.

Authors:  Sarah K Browne; Peter D Burbelo; Ploenchan Chetchotisakd; Yupin Suputtamongkol; Sasisopin Kiertiburanakul; Pamela A Shaw; Jennifer L Kirk; Kamonwan Jutivorakool; Rifat Zaman; Li Ding; Amy P Hsu; Smita Y Patel; Kenneth N Olivier; Viraphong Lulitanond; Piroon Mootsikapun; Siriluck Anunnatsiri; Nasikarn Angkasekwinai; Boonmee Sathapatayavongs; Po-Ren Hsueh; Chi-Chang Shieh; Margaret R Brown; Wanna Thongnoppakhun; Reginald Claypool; Elizabeth P Sampaio; Charin Thepthai; Duangdao Waywa; Camilla Dacombe; Yona Reizes; Adrian M Zelazny; Paul Saleeb; Lindsey B Rosen; Allen Mo; Michael Iadarola; Steven M Holland
Journal:  N Engl J Med       Date:  2012-08-23       Impact factor: 91.245

5.  Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans.

Authors:  Conny Höflich; Robert Sabat; Simone Rosseau; Bettina Temmesfeld; Hortense Slevogt; Wolf-Dietrich Döcke; Gerald Grütz; Christian Meisel; Elke Halle; Ulf B Göbel; Hans-Dieter Volk; Norbert Suttorp
Journal:  Blood       Date:  2003-08-28       Impact factor: 22.113

6.  Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy.

Authors:  Ting-Ting Liu; Shao-Wen Weng; Ming-Chung Wang; Wan-Ting Huang
Journal:  APMIS       Date:  2015-12-14       Impact factor: 3.205

7.  Disseminated Mycobacterium avium complex infection in a patient with autoantibody to interferon-gamma.

Authors:  Yasuhiro Tanaka; Toshiyuki Hori; Ken Ito; Tomoko Fujita; Takayuki Ishikawa; Takashi Uchiyama
Journal:  Intern Med       Date:  2007-07-02       Impact factor: 1.271

8.  Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma.

Authors:  Beate Kampmann; Cheryl Hemingway; Alick Stephens; Robert Davidson; Anna Goodsall; Suzanne Anderson; Mark Nicol; Elisabeth Schölvinck; David Relman; Simon Waddell; Paul Langford; Brian Sheehan; Lynn Semple; Katalin A Wilkinson; Robert J Wilkinson; Stanley Ress; Martin Hibberd; Michael Levin
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

9.  The first US domestic report of disseminated Mycobacterium avium complex and anti-interferon-γ autoantibodies.

Authors:  Elise O'Connell; Lindsey B Rosen; Richard W LaRue; Valeria Fabre; Michael T Melia; Paul G Auwaerter; Steven M Holland; Sarah K Browne
Journal:  J Clin Immunol       Date:  2014-08-23       Impact factor: 8.542

10.  Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections.

Authors:  Chih-Yu Chi; Chia-Hao Lin; Mao-Wang Ho; Jing-Ya Ding; Wen-Chi Huang; Han-Po Shih; Chun-Fu Yeh; Chang-Phone Fung; Hsin-Yun Sun; Ching-Tai Huang; Ting-Shu Wu; Chih-Yen Chang; Yuag-Meng Liu; Jia-Yih Feng; Wei-Kai Wu; Lih-Shinn Wang; Chung-Hao Tsai; Cheng-Mao Ho; Huang-Shen Lin; Hung-Jen Chen; Po-Chang Lin; Wei-Chin Liao; Wei-Ting Chen; Chia-Chi Lo; Shang-Yu Wang; Chen-Yen Kuo; Chen-Hsiang Lee; Cheng-Lung Ku
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more
  7 in total

Review 1.  Anticytokine autoantibodies: Autoimmunity trespassing on antimicrobial immunity.

Authors:  Aristine Cheng; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2022-01       Impact factor: 14.290

2.  Case Report: Acquired Disseminated BCG in the Context of a Delayed Immune Reconstitution After Hematological Malignancy.

Authors:  Vincent Gies; Yannick Dieudonné; Florence Morel; Wladimir Sougakoff; Raphaël Carapito; Aurélie Martin; Noëlle Weingertner; Léa Jacquel; Fabrice Hubele; Cornelia Kuhnert; Sophie Jung; Frederic Schramm; Pierre Boyer; Yves Hansmann; François Danion; Anne-Sophie Korganow; Aurélien Guffroy
Journal:  Front Immunol       Date:  2021-08-03       Impact factor: 7.561

Review 3.  Minireview: Insights into anti-interferon-γ autoantibodies.

Authors:  Kriangkrai Chawansuntati; Kritsadee Rattanathammethee; Jiraprapa Wipasa
Journal:  Exp Biol Med (Maywood)       Date:  2021-01-11

Review 4.  Pulmonary non-tuberculous mycobacterial infections: current state and future management.

Authors:  Kai Ling Chin; Maria E Sarmiento; Nadine Alvarez-Cabrera; Mohd Nor Norazmi; Armando Acosta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-18       Impact factor: 3.267

Review 5.  Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection.

Authors:  Long-Fang Chen; Cheng-De Yang; Xiao-Bing Cheng
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

6.  Human autoantibodies underlying infectious diseases.

Authors:  Anne Puel; Paul Bastard; Jacinta Bustamante; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2022-03-23       Impact factor: 14.307

Review 7.  Mycobacterial diseases in patients with inborn errors of immunity.

Authors:  Stéphanie Boisson-Dupuis; Jacinta Bustamante
Journal:  Curr Opin Immunol       Date:  2021-07-24       Impact factor: 7.268

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.